Physician profile
Gordon Weigle
NPI 1093768616
$1,220.68
in general payments reported to CMS, 2019-2025
16 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.71 · 2023: $361 · 2024: $564 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $404.39 | 2023-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $318.21 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $95.87 | 2023-2024 | Rybelsus, Ozempic |
| Lundbeck LLC | $51.43 | 2022-2025 | Rexulti |
| Xeris Pharmaceuticals, INC. | $49.69 | 2023 | Gvoke Hypopen |
| Corcept Therapeutics | $49.58 | 2024-2025 | Korlym |
| Lilly USA, LLC | $40.07 | 2022-2023 | Mounjaro |
| Pfizer INC. | $36.00 | 2023 | |
| Renalytix Ai, INC. | $34.17 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Exact Sciences Corporation | $32.28 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Alnylam Pharmaceuticals INC. | $27.10 | 2023 | Onpattro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.33 | 2025 | Caplyta |
| Dynavax Technologies Corporation | $16.79 | 2023 | Heplisav-B |
| Stryker Corporation | $15.68 | 2025 | Clottriever Bold Catheter |
| Phathom Pharmaceuticals, INC. | $13.90 | 2024 | Voquezna |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Weigle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.